Targeting signal transduction for disease therapy

This publication has 40 references indexed in Scilit:

• Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
  Nature, 1996
• Tumor Necrosis Factor α Increases Tyrosine Phosphorylation of a 23-kDa Nuclear Protein in U937 Cells Through Ceramide Signaling Pathway
  Biochemical and Biophysical Research Communications, 1995
• A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen
  Current Biology, 1995
• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275
  Biochemical and Biophysical Research Communications, 1994
• Signalling pathways as target for anticancer drug development
  Pharmacology & Therapeutics, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene
  Gene, 1992
• Inhibition of platelet-derived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostins
  Experimental Cell Research, 1992
• Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
  Journal of Clinical Immunology, 1991